All results
1 results for targeted therapy directed genetic testing patients advanced solid tumors
-
NRG-BR009: Testing the addition of chemo to SOC in breast cancer patients at high risk of recurrence
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to…
- Ages
- 18 Years - 60 Years
- Sexes
- Female